AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 57 filers reported holding AKCEA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,011,000 | -17.3% | 110,837 | -37.5% | 0.00% | 0.0% |
| Q2 2020 | $2,431,000 | +5.2% | 177,415 | +9.8% | 0.00% | 0.0% |
| Q1 2020 | $2,310,000 | -10.5% | 161,529 | +6.0% | 0.00% | 0.0% |
| Q4 2019 | $2,582,000 | +56.5% | 152,404 | +42.2% | 0.00% | 0.0% |
| Q3 2019 | $1,650,000 | -20.7% | 107,159 | +20.8% | 0.00% | 0.0% |
| Q2 2019 | $2,081,000 | -15.3% | 88,723 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $2,456,000 | -2.2% | 86,688 | +4.1% | 0.00% | 0.0% |
| Q4 2018 | $2,511,000 | -1.3% | 83,287 | +14.6% | 0.00% | 0.0% |
| Q3 2018 | $2,545,000 | +51.0% | 72,653 | +2.2% | 0.00% | +100.0% |
| Q2 2018 | $1,685,000 | -13.6% | 71,060 | -6.7% | 0.00% | -50.0% |
| Q1 2018 | $1,950,000 | +65.8% | 76,142 | +12.4% | 0.00% | +100.0% |
| Q4 2017 | $1,176,000 | -28.9% | 67,718 | +13.3% | 0.00% | 0.0% |
| Q3 2017 | $1,654,000 | – | 59,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |